Stifel Initiates Coverage On AnaptysBio With Buy Rating, Announces Price Target of $50
Stifel Initiates Coverage On AnaptysBio With Buy Rating, Announces Price Target of $50
Stifel以買入評級啓動對AnaptysBio的報道,宣佈目標股價爲50美元
Stifel analyst Alex Schwartz initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Buy rating and announces Price Target of $50.
Stifel分析師亞歷克斯·施瓦茨以買入評級開始對AnaptysBio(納斯達克股票代碼:ANAB)進行報道,並宣佈目標股價爲50美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。